Evaluation of Pembrolizumab Monotherapy Efficacy in Advanced Non-Small-Cell Lung Cancer by Serial Monitoring of Circulating Tumor DNA Using Next-Generation Sequencing

INTRODUCTION: Pembrolizumab is widely used in advanced non-small-cell lung cancer (NSCLC) patients with positive programmed death-ligand 1 (PD-L1). However, efficacy evaluation along treatment by serial monitoring of circulating tumor DNA (ctDNA) using next-generation sequencing remained to be well...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Buhai, Fan, Yaqin, Zhang, Liying, Liu, Liqin, Ma, Yutong, Ma, Xiaosong, Huang, Yuxiang, Wu, Yinxia, Liang, Yichen, Xu, Yang, Wu, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859670/
https://www.ncbi.nlm.nih.gov/pubmed/35197718
http://dx.doi.org/10.1177/11795549221075326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859670/
https://www.ncbi.nlm.nih.gov/pubmed/35197718
http://dx.doi.org/10.1177/11795549221075326

Ejemplares similares